Form 4 · Filed Jun 1, 2026, 08:11 PM UTC
ASND/Ascendis Pharma A/S
BIENAIME JEAN JACQUES — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026 | P | buy | 200 | $224 | $44,752 | 600 |
| May 29, 2026 | P | buy | 200 | $222 | $44,460 | 800 |
| May 29, 2026 | P | buy | 100 | $224 | $22,350 | 900 |
Source: SEC EDGAR raw filing ↗ · Accession 0001610717-26-000177